NCT02814968View on ClinicalTrials.gov

PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2020

Study Completion Date

December 31, 2020

Conditions
Prostate Cancer Metastatic
Interventions
DRUG

Enzalutamide

DEVICE

18-FDG PET/CT

DEVICE

Whole body MRI

DEVICE

Bone scan

Trial Locations (1)

2333 ZA

Leiden University Medical Center, Leiden

All Listed Sponsors
collaborator

Centre for Human Drug Research, Netherlands

OTHER

lead

The European Uro-Oncology Group

OTHER

NCT02814968 - PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide | Biotech Hunter | Biotech Hunter